Trial
NCT04235049
Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
Merck Sharp & Dohme LLC; Maryland Department of Public Safety and Correctional Services
Condition
HCV Infection
Intervention
Glecaprevir/pibrentasvir
Why stopped
Department of Corrections unable to support study at this time and find agreement on publication issue.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-06